The companies entered into the antibody-drug conjugate (ADC) collaboration in April 2005 to provide MedImmune with access to Seattle Genetics’ ADC technology for antibodies targeting up to two
Deerfield’s commitment of funding, which includes $7.5 million upfront, is in the form of an interest-bearing loan that can be drawn down at pre-determined intervals over a three-year
The purchase price is subject to adjustment based on ReliaGene’s working capital at closing and future revenue levels. A portion of the purchase price will be held in
The study will be performed in healthy volunteers who will receive the drug subcutaneously. The evaluations will include safety, tolerability, pharmacokinetics and several pharmacodynamic endpoints, including endogenous messenger
Emisphere added that it will retain its scientific staff and laboratory facilities in Tarrytown. The move to New Jersey is one of several real estate initiatives planned by
The companies have initially targeted four immediate release opioid analgesic products, including Acurox tablets (oxycodone HCl, niacin, and a unique combination of other ingredients), for treating moderate to
The net proceeds to the company of the offering were approximately $24 million, after payment of underwriting discounts and commissions, but excluding estimated offering expenses. Bionovo will use
Under the terms of the agreement, Merck receives worldwide exclusive rights to Heplisav, will fund future vaccine development and be responsible for commercialization. Dynavax will receive an initial
Prime Healthcare Services (PHS) will operate Centinela Hospital Medical Center (CHMC) as an acute-care facility with all services presently provided including emergency department services, medical/surgical services, obstetric services
Under the terms of the acquisition agreement, Hubei Longdan is obligated to pay all of All-State’s expenses relating to the transaction, as well as expenses relating to maintenance
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.